Open Access
Research Paper
Peer Reviewed

Paper Title

A Review on Abelmoschus Esculentus Linn Act as an Antidiabetic Agent

Article Identifiers

Registration ID: IJNRD_304068

Published ID: IJNRD2502228

: Click Here to Get

Keywords

Abelmoschus Esculentus, Medicinal Plants, natural remedies, Anti-diabetic Properties, hyperglycaemia.

Abstract

The aim of this review article is to highlight the anti-diabetic properties of Okra. Diabetes Mellitus is a leading cause of morbidity and mortality. While it remains as incurable disease, there is ongoing research on natural remedies to minimize toxic effects and provide simplest treatments. As plant-based resources become a major focus for discovering of new drugs. Abelmoschus esculentus (Okra) is being explored as a potential alternative drug to current diabetes medications, though further research is needed for analysing its great potentials. Belonging to the Malvaceae family, Okra is a nutritional plant used for both medicinal and cooking purposes. Okra (Abelmoschus esculentus Linn.) is an annual medicinal herb rich in antioxidants, bioactive polysaccharides and fibers. Traditionally it has been used in Indian medicine system to treat diabetes mellitus disease. The seeds of Abelmoschus esculentus, known as "monech" seeds, they show potential in the development of antidiabetic drugs due to its ability to reduce hyperglycaemia. Diabetes is a global health issue due to its numerous adverse effects on human health. Several studies have shown that okra seeds can help to control hyperglycaemia and potentially prevent the onset of action of diabetes.

How To Cite (APA)

Sneha Rajesh Prajapati, Prayanjani Surykant Munde, Rohit Dipak Kakad, & Nayana Sharad Gadhave (February-2025). A Review on Abelmoschus Esculentus Linn Act as an Antidiabetic Agent. INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 10(2), c237-c243. https://ijnrd.org/papers/IJNRD2502228.pdf

Issue

Other Publication Details

Paper Reg. ID: IJNRD_304068

Published Paper Id: IJNRD2502228

Downloads: 000122006

Research Area: Pharmacy All

Author Type: Indian Author

Country: Thane, Maharashtra, India

Published Paper PDF: https://ijnrd.org/papers/IJNRD2502228.pdf

Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2502228

About Publisher

Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)

UGC CARE JOURNAL PUBLICATION | ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG

Copyright & License

© 2025 — Authors hold the copyright of this article. This work is licensed under a Creative Commons Attribution 4.0 International License. and The Open Definition.

You are free to share, adapt, and redistribute the material, provided proper credit is given to the original author. 🛡️ Disclaimer: The content, data, and findings in this article are based on the authors’ research and have been peer-reviewed for academic purposes only. Readers are advised to verify all information before practical or commercial use. The journal and its editorial board are not liable for any errors, losses, or consequences arising from its use.
CC OpenContant

Publication Timeline

Peer Review
Through Scholar9.com Platform

Article Preview: View Full Paper

Call For Paper

Call For Paper - Volume 10 | Issue 11 | November 2025

IJNRD is a Scholarly Open Access, Peer-Reviewed, Refereed, and UGC CARE Journal Publication with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost, and Transparent Peer Review Journal Publication that adheres to the UGC CARE 2025 Peer-Reviewed Journal Policy and aligns with Scopus Journal Publication standards to ensure the highest level of research quality and credibility.

IJNRD offers comprehensive Journal Publication Services including indexing in all major databases and metadata repositories, Digital Object Identifier (Crossref DOI) assignment for each published article with additional fees, citation generation tools, and full Open Access visibility to enhance global research reach and citation impact.

The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse academic and professional fields. The journal promotes global knowledge exchange among researchers, developers, academicians, engineers, and practitioners, serving as a trusted platform for innovative, peer-reviewed journal publication and scientific collaboration.

Indexing Coverage: Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many other recognized academic repositories.

How to submit the paper?

You can now publish your research in IJNRD. IJNRD is a Transparent Peer-Reviewed Open Access Journal Publication (Refereed Journal), aligning with New UGC and UGC CARE recommendations.


For more details, refer to the official notice: UGC Public Notice


Submit Paper Online

Important Dates for Current issue

Paper Submission Open For: November 2025

Current Issue: Volume 10 | Issue 11 | November 2025

Impact Factor: 8.76

Last Date for Paper Submission: Till 30-Nov-2025

Notification of Review Result: Within 1-2 Days after Submitting paper.

Publication of Paper: Within 01-02 Days after Submititng documents.

Frequency: Monthly (12 issue Annually).

Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.

Subject Category: Research Area

Call for Paper: More Details

Approval, Licenses and Indexing: More Details